Nanollose

Nanollose is an Australian biomaterials company that develops innovative, eco-friendly cellulose technologies using a proprietary microbial fermentation process. By converting liquid organic waste into high-purity microbial cellulose, the company creates sustainable alternatives to traditional tree-based fibers for the textile and medical industries. In the healthcare sector, Nanollose focuses on high-performance materials for wound care, medical membranes, and advanced drug delivery systems. Their lead textile product, Nullarbor, is produced in collaboration with global partners, while their medical division explores applications in regenerative medicine and tissue engineering. The company's technology offers a unique value proposition by providing a high-purity material with superior structural properties compared to plant-derived cellulose. Nanollose is publicly traded on the Australian Securities Exchange and continues to expand its portfolio of sustainable biomaterial solutions.